High mortality among tuberculosis patients on treatment in Nigeria: a retrospective cohort study.
Aishatu L AdamuMuktar A GadanyaIsa S AbubakarAbubakar M JiboMusa M BelloAuwalu U GajidaMusa M BabashaniIbrahim AbubakarPublished in: BMC infectious diseases (2017)
We attribute early deaths in this relatively young cohort to delay in diagnosis and treatment of TB, inadequate treatment of drug-resistant TB, and poor ART access. Considerable expansion and improvement in quality of diagnosis and treatment services for TB and HIV are needed to achieve the sustainable development goal of reducing TB deaths by 95% by 2035.
Keyphrases
- drug resistant
- mycobacterium tuberculosis
- end stage renal disease
- multidrug resistant
- antiretroviral therapy
- hiv infected
- healthcare
- chronic kidney disease
- hiv aids
- human immunodeficiency virus
- ejection fraction
- acinetobacter baumannii
- newly diagnosed
- mental health
- hepatitis c virus
- peritoneal dialysis
- risk factors
- type diabetes
- cystic fibrosis
- middle aged